GlassScriptPhysician profile
Shooka Esmaeeli
NPI 1841813284
$1,716.99
in general payments reported to CMS, 2019-2025
10 companies · $1,009 in 2025
The $1,009 reported for 2025 was more than what 94% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $32.37 · 2023: $190 · 2024: $486 · 2025: $1,009.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,607 · Travel and Lodging: $77.56.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,607.06 |
| Travel and Lodging | $77.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $496.71 | 2023-2025 | Intellis Adaptivestim, Inceptiv, Kyphon Express II Kyphopak Tray |
| Spr Therapeutics, INC | $336.92 | 2024-2025 | Sprint Pns System |
| Globus Medical, INC. | $179.20 | 2025 | Senza |
| Saluda Medical Americas, INC. | $142.45 | 2024 | Evoke |
| Biotronik Nro, INC. | $134.76 | 2024-2025 | Prospera |
| Avanos Medical | $103.14 | 2025 | Coolief Cooled Radiofrequency |
| Vertos Medical, INC. | $101.22 | 2024 | Mild Device Kit |
| Abbvie INC. | $99.82 | 2023 | |
| Averitas Pharma INC. | $90.40 | 2024 | Qutenza |
| Medical Device Business Services, INC. | $32.37 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shooka Esmaeeli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.